Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05941351

fixAtion of skiN Flaps After Mastectomy Using ruNning or Interrupted suturEs for Combatting Seroma

Rationale: Flap fixation significantly reduces the incidence of seroma formation after mastectomy. Therefore, research should focus on finding the most optimal way to secure the skin flaps to the pectoral muscle. Previous studies have compared running sutures, interrupted sutures and tissue glue application to conventional wound closure. A recent systematic review with network meta-analysis indicated running sutures as the most optimal technique, however direct comparisons and high quality articles were lacking.

Objective: This prospective trial aims to directly compare running sutures with interrupted sutures in order to prevent complications in patients undergoing a mastectomy.

Study design: This trial will combine a retrospective cohort from the previous SARA-trial in Zuyderland MC with a randomised prospective trial. This study design was chosen to acquire a sample size with sufficient power and the ability to conduct this study in an acceptable time frame.

Study population: A retrospective cohort of patients participating in the SARA trial (RCT) and a prospective cohort of patients undergoing a mastectomy for breast cancer.

Intervention: Group 1: Flap fixation after mastectomy with running sutures. Group 2: Flap fixation after mastectomy with interrupted sutures.

Main study parameters/endpoints: The primary endpoint is the incidence of complications requiring interventions in both groups, including clinically significant seroma, infections and bleeding complications. Secondarily, the length of the procedure and cosmetic results will be compared.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: When participating, patients will undergo 3 additional outpatient clinic visits. Study visits will be combined with regular visits where possible, including the first postoperative visit after 7-10 days and either the 6 week or 3 month visit.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female sex.
  • 18 years or older.
  • Indication for mastectomy.

Exclusion criteria

  • Patients undergoing breast conserving therapy
  • Patients undergoing direct breast reconstruction
  • Patients undergoing modified radical mastectomy
  • Unable to comprehend implications and extent of study and sign for informed consent

Treatment and study plan

flap fixation

Procedure

flap fixation using running or interrupted sutures

Primary outcomes

  1. Complications requiring an intervention

    Time frame: 3 months

    The main study parameter is the incidence of complications requiring interventions in both groups. This consists of:

    • Clinically significant seroma, requiring aspirations in the case of:
    • Pain or discomfort for the patient caused by large amounts of seroma characterised by tenderness of the skin.
    • Signs of infection (redness, swelling, pain).
    • Signs of delayed wound healing (wound breakdown, necrosis, seroma leakage).
    • Surgical site infections, requiring oral/iv antibiotics or surgical drainage.
    • Bleeding complications, requiring re-intervention, aspiration or surgical debridement.

Secondary outcomes

  1. Surgery time

    Time frame: during surgery

    surgery time in minutes

  2. Cosmetic outcome

    Time frame: 3 months

    • Cosmetic results measured using a numeric rating score (NRS) from 0-10, in which 0 equals very dissatisfied with the cosmetic results and 10 equals very satisfied with the results.

Study contacts

Contact information is provided by the study sponsor or research team.

Merel Spiekerman van Weezelenburg, MD

CONTACT

[email protected]

+31884597777

Sponsors and collaborators

Lead sponsor

Zuyderland Medisch Centrum

Other

Registry information

Acronym: ANNIE

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Jul 12, 2023
Registry last updated
Jul 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.